Language:
Instant News and Commentaries
2026-10-15
07:16
XPENG CEO He Xiaopeng Calls for Deeper Global Collaboration at the 2026 Paris Automotive Summit, Highlighting "XPENG AI Engineering"

  • Mr. He Xiaopeng, Chairman & CEO, becomes the first Chinese automotive CEO to deliver a keynote in the history of the Paris Automotive Summit, calling for greater industry collaboration as AI, electrification and globalization reshapes the automotive sector.
  • Mr. He Xiaopeng introduced XPENG AI Engineering, calling for open collaboration and opening XPENG's full-stack technologies and engineering capabilities to global partners, from vehicle platforms to Physical AI.
  • XPENG highlighted NGP which is aiming for global market expansion in 2027, alongside clear milestones for its humanoid robot, IRON, targeting mass production in late 2026, initial deliveries in H1 2027, and a European rollout in H2 2027.

PARIS, Oct. 15, 2026 /PRNewswire/ -- Mr. He Xiaopeng, Chairman & CEO of XPeng Inc. ("XPENG" or the "Company," NYSE: XPEV; HKEX: 9868), a leading global Physical AI company, today called for deeper collaboration across the global automotive industry, as he became the first Chinese automotive CEO to deliver a keynote in the history of the Paris Automotive Summit.

Speaking to automotive industry leaders in Paris, Mr. He outlined how AI, electrification and smart technologies are reshaping the automotive industry, creating new opportunities for technology collaboration across the sector.

The theme of his keynote speech was "Navigating the AI Era: Open Collaboration for a Smarter Future," where he outlined XPENG AI Engineering, XPENG's strategy to combine its Physical AI technology with deeper ecosystem partnerships across Europe and globally.

He emphasized that no single manufacturer holds all the advantages required for the next generation of smart mobility. To accelerate this transition, XPENG is opening its in-house tech stack and engineering resources to key international partners.

Open Technology Collaboration for the AI Era: XPENG AI Engineering

XPENG's approach to collaboration is rooted in its evolution as a Physical AI company, with full-stack technologies spanning chips, models and applications across intelligent vehicles, robotaxis, humanoid robots and flying cars. In intelligent driving, XPENG highlighted NGP powered by VLA 2.0, designed to advance directly from L2 to L4 and deliver the same core capability across China and Europe, as the company prepares to bring advanced intelligent driving to global markets in 2027.

XPENG is also advancing the commercialization of its humanoid robot, IRON, with mass production targeted for late 2026, deliveries beginning in the first half of 2027, and a European rollout planned for the second half of 2027.

As AI expands into the physical world, XPENG believes industry transformation will be driven both from within and beyond automotive. To usher in this new era, XPENG is opening its proprietary technologies and engineering toolchains to global partners - spanning vehicle platforms, E/E architecture, batteries, e-drives, and modular innovations like the AI BOX, Turing AI chip, and Turing physical world foundation model.

Through XPENG AI Engineering, the company is pursuing a model built around complementary strengths, flexible collaboration and independent innovation, enabling partners to co-develop differentiated products while building their own technology capabilities over time.

As a proven example of this mutually beneficial approach, Mr. He highlighted XPENG's strategic collaboration with Volkswagen Group, which brings together XPENG's intelligent-driving and software capabilities with Volkswagen's vehicle engineering and testing expertise.

This latest development builds on XPENG's continued investment in technology and talent. In the first half of 2026, XPENG invested approximately €770 million in R&D.

"Partnership starts with trust, and after trust comes openness," said Mr. He. "We welcome global partners to work with us, learn from each other and bring our strengths together. To bring technology to life and build the future together."

In Europe, For Europe, With Europe

Mr. He also reinforced XPENG's long-term "In Europe, For Europe, With Europe" commitment, centered on producing in Europe, designing for European users and partnering with the region's industrial ecosystem.

XPENG has put four models into production in Europe within one year, including the G6, G9, P7+ and the latest G9L. Its European R&D center serves as a hub for EU homologation and certification, language and interaction localization, intelligent-driving validation, European chassis and handling tuning, and charging-network integration.

XPENG continues to deepen collaboration across Europe's automotive and technology ecosystem, working with local partners as it expands its capabilities in the region.

ENDS

About XPENG

XPENG is a leading global Physical AI company, dedicated to bringing artificial intelligence into the physical world to reshape future mobility and smart living. Through in-house R&D, XPENG has developed a full-stack Physical AI architecture spanning Turing AI chips, world foundation models, and highly integrated software and hardware applications. This unified technology foundation powers an expansive product portfolio of smart EVs, robotaxis and humanoid robots, advancing the deployment of Physical AI at scale.

Headquartered in Guangzhou, China, XPENG is dual-primary listed on the New York Stock Exchange and the Hong Kong Stock Exchange. With global capabilities across R&D, manufacturing, sales and services, XPENG drives continuous technological innovation and fosters an open Physical AI ecosystem, making life smarter, safer and better for users worldwide.

For more information, please visit https://www.xpeng.com/.

Information Provided by PR Newswire [Disclaimer]
06:40
J&T Express Average Daily Parcel Volume Reaches 104.2 Million in Q3 2026; Exceeds 100 Million for Second Consecutive Quarter

China Parcel Volume Up 15.3% YoY; Other Markets Parcel Volume Up 159.5% YoY

HONG KONG, Oct. 15, 2026 /PRNewswire/ -- J&T Global Express Limited (01519.HK), a global logistics service provider, today announced its business update and operating metrics for the third quarter ended 30 September 2026. During the period, the Company's global parcel volume reached 9.58 billion, up 24.8% YoY, with average daily parcel volume reaching 104.2 million and exceeding 100 million for the second consecutive quarter. In the first nine months of 2026, the Company's global parcel volume reached 27.09 billion, up 25.0% YoY, with average daily parcel volume reaching 99.2 million. The Company's overall business momentum continued to strengthen, with its leading position in Southeast Asia maintained, robust growth recorded in Other Markets and growth in China rising to its highest level of the year.

In Southeast Asia, J&T Express further consolidated its market leadership and continued to deliver rapid growth in the third quarter, with parcel volume reaching 2.89 billion, up 44.5% YoY, and average daily parcel volume reaching 31.4 million. Parcel volume for the first nine months reached 8.41 billion, up 61.0% YoY. The Company continued to enhance its regional network capacity and fulfillment capabilities, promote automation upgrades across its outlets, and further increase automation levels. As of September 30, 2026, the number of sorting centers in Southeast Asia had increased by 10 from the end of 2025 to 131, the number of line-haul vehicles had increased by approximately 100 to 5,900, and the number of automated sorting lines had increased by 17 to 81, supporting the region's continued business growth.

In China, J&T Express proactively adapted to industry trends and deepened its engagement with diversified customer groups, with a focus on enhancing its service capabilities for customers in key categories such as apparel, beauty products and 3C electronics, as well as specialized segments including specialty agricultural products and fruit. In the third quarter, parcel volume in China reached 6.43 billion, with average daily parcel volume reaching 69.9 million, up 15.3% YoY, marking a quarter-by-quarter acceleration in growth. Parcel volume for the first nine months reached 18.04 billion, up 11.5% YoY. As of September 30, 2026, the number of line-haul vehicles in China had increased by approximately 500 from the end of 2025 to 7,700, including an increase of approximately 300 self-owned line-haul vehicles to 5,600, further strengthening the Company's network transportation capabilities.

In Other Markets, parcel volume reached 270.8 million in the third quarter, up 159.5% YoY, with average daily parcel volume reaching 2.9 million as the YoY growth rate continued to accelerate. Parcel volume for the first nine months reached 635.8 million, up 135.2% YoY. The Company continued to seize e-commerce development and cross-border logistics opportunities in regions such as Latin America and the Middle East, deepening cooperation with global e-commerce and short-video livestreaming platforms including TikTok, SHEIN, Temu, Kwai and AliExpress, as well as local e-commerce platforms such as Mercado Libre, to further expand its business opportunities in emerging markets.

As its global business continued to expand, J&T Express further strengthened its global network. As of September 30, 2026, the Company's global network comprised 20,300 outlets, an increase of approximately 1,000 from the end of 2025; 292 sorting centers, an increase of 46; and 457 automated sorting lines, an increase of 44. Going forward, J&T Express will continue to enhance its network capabilities, fulfillment efficiency and service quality, deepen localized operations in line with the development stage of each market, and advance AI applications, automation and digital capabilities to support the long-term, steady growth of its global business.

Information Provided by PR Newswire [Disclaimer]
2026-10-13
19:16
ESMO 前瞻 | 科倫博泰多項重磅研究成果亮相

成都2026年10月13日 /美通社/ -- 2026年歐洲腫瘤內科學會(ESMO)大會將於10月23日至27日在西班牙馬德里舉行。四川科倫博泰生物醫藥股份有限公司(「科倫博泰」或「公司」,6990.HK)將於此次大會上公佈多項臨床研究成果,涵蓋靶向人滋養細胞表面抗原2(TROP2)的抗體偶聯藥物(ADC)蘆康沙妥珠單抗(sac-TMT,亦稱SKB264/MK-2870)(佳泰萊®)及其他ADC藥物的相關數據。

其中,蘆康沙妥珠單抗(sac-TMT)多項研究成果入選口頭報告,包括OptiTROP-Lung04和OptiTROP-Lung06 III期研究均入選最新突破性摘要(LBA)及「轉移性非小細胞肺癌」專場,並將於同一時段以優選口頭報告(Proffered paper)形式發佈;此外,由默沙東[1]主導開展的全球性關鍵III期TroFuse-005試驗數據也將首次公佈,並將在ESMO主席論壇(Presidential Symposium)重點展示。

上述研究及科倫博泰其他研究的摘要標題已於ESMO官方網站公佈,詳情如下:

肺癌

蘆康沙妥珠單抗(sac-TMT)聯合帕博利珠單抗對比化療聯合帕博利珠單抗一線治療PD-L1陰性晚期非鱗狀NSCLC:隨機III期OptiTROP-Lung06研究結果

LBA66-優選口頭報告(Proffered paper) | 轉移性非小細胞肺癌

當地時間10月25日10:15-11:45

蘆康沙妥珠單抗(sac-TMT)對比含鉑化療治療EGFR-TKI治療後進展的EGFR突變非小細胞肺癌(NSCLC):III期OptiTROP-Lung04研究總生存期最終分析結果

LBA67-優選口頭報告(Proffered paper) | 轉移性非小細胞肺癌

當地時間10月25日10:15-11:45

新型靶向B7-H3抗體偶聯藥物SKB500治療廣泛期小細胞肺癌:I期研究結果

3816RO-快速口頭報告| 非轉移性非小細胞肺癌及其他胸部惡性腫瘤

當地時間10月26日 10:15-11:45


乳腺癌 

蘆康沙妥珠單抗(sac-TMT) 對比化療治療既往接受過治療的局部復發或轉移性三陰性乳腺癌:III期OptiTROP-Breast01研究總生存期最終分析結果

4639RO-快速口頭報告| 乳腺癌-晚期階段

當地時間10月26日 10:15-11:45


婦科腫瘤

蘆康沙妥珠單抗(sac-TMT) 治療既往接受過治療的晚期或復發性子宮內膜癌:III期TroFuse-005/ENGOT-en23/GOG-3095研究結果

LBA11-優選口頭報告(Proffered paper) |主席論壇(Presidential Symposium)

當地時間10月26日16:30-18:15

蘆康沙妥珠單抗(sac-TMT)聯合帕博利珠單抗治療含鉑治療後進展的晚期錯配修復完整(pMMR)子宮內膜癌(EC):II期2870-002/SKB264-II-06研究結果

1259P-壁報| 婦科腫瘤

當地時間10月26日 12:00-12:45


泌尿生殖系統腫瘤

蘆康沙妥珠單抗(sac-TMT)聯合帕博利珠單抗治療局部晚期或轉移性尿路上皮癌(la/mUC):II期2870-002/SKB264-II-06研究結果

4739RO-快速口頭報告| 泌尿生殖系統腫瘤-腎及尿路上皮

當地時間10月24日 10:15-11:45

關於蘆康沙妥珠單抗(sac-TMT)(佳泰萊®)

作為公司的核心產品,蘆康沙妥珠單抗(sac-TMT)是一款公司擁有自主知識產權的新型TROP2 ADC,針對NSCLC、乳腺癌(BC)、胃癌(GC)、婦科腫瘤及泌尿生殖系統腫瘤等晚期實體瘤。蘆康沙妥珠單抗(sac-TMT)採用獨特雙功能連接子開發而成。該連接子一方面通過與抗TROP2單克隆抗體沙妥珠單抗形成不可逆結合,另一方面在溶酶體中可從貝洛替康衍生物拓撲異構酶I抑制劑有效載荷(KL610023) pH敏感裂解,從而最大限度將有效載荷遞送至腫瘤細胞,藥物抗體比(DAR)達到7.4。蘆康沙妥珠單抗(sac-TMT)通過重組抗TROP2人源化單克隆抗體特異性識別腫瘤細胞表面的TROP2,其後被腫瘤細胞內吞併於細胞內釋放有效載荷KL610023。KL610023可誘導腫瘤細胞DNA損傷,進而導致細胞週期阻滯及細胞凋亡。此外,其亦於腫瘤微環境中釋放KL610023。鑒於KL610023具有細胞膜滲透性,其可實現旁觀者效應,即殺死鄰近的腫瘤細胞。

於2022年5月,公司授予默沙東(美國新澤西州羅威市默克公司的商號)在大中華區(包括中國內地、香港、澳門及台灣)以外的所有地區開發、使用、製造及商業化蘆康沙妥珠單抗(sac-TMT)的獨家權利。

截至目前,蘆康沙妥珠單抗(sac-TMT)的4項適應症已於中國獲批上市,分別用於:1)既往至少接受過2種系統治療(其中至少1種治療針對晚期或轉移性階段)的不可切除的局部晚期或轉移性三陰性乳腺癌(TNBC);2)經表皮生長因子受體-酪氨酸激酶抑制劑(EGFR-TKI)和含鉑化療治療後進展的EGFR基因突變陽性的局部晚期或轉移性非鱗狀NSCLC;3)經EGFR-TKI治療後進展的EGFR基因突變陽性的局部晚期或轉移性非鱗狀NSCLC;4)既往接受過內分泌治療且在晚期疾病階段接受過至少一線化療的不可切除或轉移性的激素受體陽性(HR+)且人類表皮生長因子受體2陰性(HER2-) (免疫組織化學(IHC) 0、IHC 1+或IHC 2+/原位雜交(ISH)-) BC;其中前2項適應症已經被納入醫保範圍,將為更多乳腺癌和非小細胞肺癌患者帶來臨床獲益。此外,蘆康沙妥珠單抗(sac-TMT)已獲國家藥品監督管理局(NMPA)授予6項突破性療法認定(BTD)。

蘆康沙妥珠單抗(sac-TMT)是全球首個在肺癌適應症獲批上市的TROP2 ADC藥物。蘆康沙妥珠單抗(sac-TMT)的兩項新增適應症上市申請已獲NMPA受理,分別用於:1)聯合帕博利珠單抗一線治療程序性細胞死亡配體1(PD-L1)腫瘤比例分數(TPS)≥1%的EGFR基因突變陰性和間變性淋巴瘤激酶(ALK)陰性的局部晚期或轉移性NSCLC;2)PD-L1綜合陽性評分(CPS)<10或早期階段接受過程序性細胞死亡蛋白1(PD-1)/PD-L1抑制劑的復發或轉移性TNBC的一線治療,以上兩項申請均被納入優先審評審批程序。目前,科倫博泰已在中國開展9項註冊性臨床研究。默沙東已啟動18項正在進行的蘆康沙妥珠單抗(sac-TMT)作為單藥療法或聯合帕博利珠單抗或其他抗癌藥物用於多種類型癌症的全球性III期臨床研究(這些研究由默沙東申辦並主導)。

關於SKB500

SKB500是公司利用OptiDCTM平台技術自主研發的一款靶向B7-H3的ADC藥物,採用定點可裂解連接子並搭載強效的拓撲異構酶I抑制劑。在臨床I期研究中,SKB500顯示出良好的療效和安全窗,擬用於治療多種晚期實體瘤。目前,SKB500治療廣泛期小細胞肺癌(ES-SCLC)以及治療晚期食管鱗狀細胞癌(ESCC)等的II期研究正在中國進行中。

關於科倫博泰

四川科倫博泰生物醫藥股份有限公司(簡稱「科倫博泰」,股票代碼:6990.HK)是科倫藥業控股子公司,專注於創新生物技術藥物及小分子藥物的研發、生產、商業化及國際合作。公司圍繞全球和中國未滿足的臨床需求,重點佈局腫瘤、自身免疫和代謝等重大疾病領域,建設國際化藥物研發與產業化平台,致力於成為在創新藥物領域國際領先的企業。公司目前擁有30餘個重點創新藥項目,其中4個項目8個適應症已獲批上市,2個項目3個適應症處於NDA階段,10餘個項目正處於臨床階段。公司成功構建了享譽國際的專有ADC及新型偶聯藥物平台OptiDCTM,已有2個ADC項目5個適應症獲批上市,多個ADC或新型偶聯藥物產品處於臨床或臨床前研究階段。更多信息請訪問官網 https://kelun-biotech.com/ 。

[1] 默沙東是美國新澤西州羅威市默克公司的商號


Information Provided by PR Newswire [Disclaimer]
12:46
Fosun International Wins Five Awards at The Asset Corporate Sustainability Leadership Awards 2026, Upgraded to Platinum

HONG KONG, Oct. 13, 2026 /PRNewswire/ -- Fosun International Limited ("Fosun International" or the "Company") (HKEX stock code: 00656) today announced that it has been awarded the prestigious "Corporate Sustainability Leadership Awards 2026 – Platinum Award" by The Asset, a leading Asia-Pacific financial publication. Building on its Gold Award win last year, this upgrade to the Platinum Award reflects Fosun International's steadfast commitment to sustainability and its continued excellence in ESG performance.

In addition to advancing from last year's Gold Award to the Platinum Award in the main category, Fosun International earned broad acclaim from The Asset for its sustained efforts in green transition, high-quality disclosure, environmental and social responsibility, and corporate governance. Demonstrating its all-around excellence, Fosun International was also honored with four major single-category awards: "Best in Disclosure & Transition", "Best Initiative in Environmental Responsibility", "Best Initiative in Social Responsibility", and "Best Sustainability Team".

Commitment to Green Transition and Transparent Disclosure Earns Widespread Recognition for ESG Excellence

Fosun International remains steadfast in its long-term commitment to sustainability and has delivered strong results across major global ESG ratings. To date, Fosun International's MSCI ESG Rating has been upgraded to the highest rating of AAA. It has been included in the S&P Global Sustainability Yearbook 2026 and also named among the Top 1% in the S&P Global Sustainability Yearbook (China Edition) 2026 for the third consecutive year. Its Hang Seng Sustainability Rating has been upgraded from AA- to AA+. It has also been selected as a constituent of the Hang Seng Corporate Sustainability Benchmark Index for the seventh consecutive year and included as a constituent of the Hang Seng ESG 50 Index. Additionally, Fosun International's FTSE Russell ESG score has consistently been higher than the global industry average and it has remained a constituent of the FTSE4Good Index Series for five consecutive years.

In recent years, Fosun International has continued to strengthen its ESG management system, fully integrating sustainability into its strategic decision-making, daily operations, and every stage of its risk management process, comprehensively strengthening the Group and its member companies' capabilities and execution in managing sustainability-related issues. At the same time, Fosun International actively supports China's "dual carbon" goals of carbon peaking and carbon neutrality, advancing initiatives in carbon neutrality, energy conservation, emissions reduction, and climate risk management. In 2026, the Company continued its voluntary disclosure practice by releasing its fourth Climate Information Disclosures Report, further enhancing the systematic approach and transparency of its climate-related disclosures.

Actively Responding to Climate Change and Protecting Biodiversity

The Group actively encourages its member companies to carry out climate actions. The Bund Finance Center (BFC), the Group's main office and a landmark in Shanghai, introduced and followed the LEED Certification, which is hailed as the "Oscar Award" in the green building industry, from the early planning stage. In 2025, 97% of Club Med's eligible resorts successfully passed audits and obtained the Green Globe Certification, the world's leading certification for sustainable tourism. Atlantis Sanya, Taicang Alps Resort and Lijiang Club Med Resort had also obtained LEED Gold Certification, demonstrating Fosun's ongoing efforts and achievements in green building and sustainable tourism.

In addition to honoring Fosun International with "Best in Disclosure & Transition" for its determined efforts to advance low-carbon transition and its high-quality disclosure, The Asset presented the Company with "Best Initiative in Environmental Responsibility" in recognition of its deep commitment to addressing climate change and protecting biodiversity. Notably, The Asset singled out the Sea Turtle Shelter project at the Atlantis Sanya aquarium for special praise.

As early as 2018, Atlantis Sanya, a subsidiary of Fosun, officially established an aquatic wildlife rescue station. Over the years, it has rescued a total of 42 wild sea turtles. On 23 May this year, World Turtle Day, the Sea Turtle Shelter at the Atlantis Sanya aquarium was officially inaugurated. Sea turtles with minor injuries are treated and released back into the sea upon full recovery, while those unable to return to the wild are given a permanent home at the shelter. Covering an area of 388 square meters, the Sea Turtle Shelter features rehabilitation pools, an educational exhibition hall, and breeding beaches designed to replicate a natural ecosystem, offering both a recovery space and long-term habitat for sea turtles.

Leveraging Innovation to Deliver Lasting Social Impact

Fosun adheres to an innovation-driven strategy, continuously delivering innovative achievements across its businesses to better serve society. In the Health business segment, Fosun targets unmet medical needs, with a strategic focus on key therapeutic areas including oncology, immunology and inflammation, and neurodegenerative diseases, while actively expanding into cardiometabolic diseases and rare diseases. This approach enables the development of high valued competitive pipelines and comprehensive healthcare solutions. Meanwhile, it continues to consolidate its core technical platforms including antibodies and antibody-drug conjugates (ADCs), small molecules, and cell therapies, while expanding into cutting-edge therapeutic modalities such as radiopharmaceuticals and small nucleic acids. Its innovative products are now available in more than 90 countries and regions worldwide. In the first half of 2026, a total of 20 indications of 7 innovative drugs were approved for launch both domestically and internationally. Meanwhile, HANSIZHUANG, HLX43, and other marketed and pipeline innovative drugs achieved several "world's first" breakthroughs.

In global public health, as of 30 June 2026, Fosun Pharma had cumulatively supplied more than 460 million vials of artesunate for injection worldwide, saving more than 92 million patients with severe malaria.

Strengthening Social Responsibility and Empowering Primary Healthcare through Technology

In order to better promote the fulfillment and implementation of corporate social responsibility, Fosun Foundation was established in 2012. It has been making unremitting efforts in areas such as global emergency relief, rural revitalization, health, education, culture and art, youth development, to create social value. In presenting Fosun International with "Best Initiative in Social Responsibility", The Asset singled out its "Rural Doctors" corporate social responsibility program and commended its introduction of the "AI Rural Doctor Assistant" into primary healthcare to expand access to healthcare and improve efficiency.

Since the launch of the Rural Doctors Program at the end of 2017, the program has covered 78 counties in 16 provinces, cities, and autonomous regions across the country, supporting 25,000 rural doctors and benefiting 3 million rural families. To harness AI to support rural revitalization and strengthen primary healthcare, Fosun Foundation partnered with the Alibaba Foundation to launch the "AI Rural Doctor Assistant", a technology-driven philanthropic initiative. It transforms the Rural Doctors' Pocket Guide, a clinical reference jointly compiled by experts, into a digital database. Rural doctors can access its intelligent question-and-answer interface at any time via a mobile phone or computer, helping them diagnose and treat patients more efficiently.

Fostering ESG culture from the top down and building a long-term ESG management system

Fosun prioritizes sustainability and has established a top-down and long-term mechanism for ESG improvement. The Company has included ESG management performance in the performance assessment not only for executive directors, but also for the CEOs of the Group and the personnel in charge of each business group. Fosun consistently fosters an ESG culture from the top down. Through regular global ESG networking workshops, ESG culture week activities and its ESG digital platform, the Company has established open and transparent communication channels across its member companies. These channels facilitate the ongoing sharing of best practices and help subsidiaries advance their ESG initiatives. The Company also maintains effective and transparent communication with stakeholders and rating agencies. The "Best Sustainability Team" award from The Asset underscores market recognition of the Company's ESG management and its efforts to advance environmental protection, social responsibility, and corporate governance.

Looking ahead, as a global enterprise rooted in China, Fosun will continue to uphold its original aspiration of "Contribution to Society". Through continuous innovation and responsible global operations, Fosun will actively shoulder more social responsibility, striving to build a more responsible, inclusive, and sustainable future.

Information Provided by PR Newswire [Disclaimer]
11:38
復星國際榮獲《財資》五項大獎 2026年企業永續領導獎躍升至「鉑金獎」

香港2026年10月13日 /美通社/ -- 復星國際有限公司(簡稱「復星國際」或「公司」)(香港聯交所股份代號:00656)近日接獲亞太區知名金融財經媒體《財資》的通知,獲其授予「2026年財資企業永續領導獎鉑金獎」(The Asset Corporate Sustainability Leadership Awards 2026 – Platinum Award)。憑借在可持續發展領域的持續投入及卓越表現,復星國際在去年斬獲金獎的基礎上再創佳績,今年進一步攀升至鉑金獎榮譽。

復星國際不僅在核心大獎上由去年的「金獎」躍升到「鉑金獎」,其在綠色轉型、高標準信息披露及在環境、社會責任與公司治理方面的長期深耕,也獲得了《財資》的全方位認可。本次《財資》同時授予復星國際四項單項大獎:
「最佳披露與轉型獎」(Best in Disclosure & Transition)
「最佳環境責任獎」(Best Initiative in Environmental Responsibility)
「最佳社會責任獎」(Best Initiative in Social Responsibility)
「最佳可持續發展團隊獎」(Best Sustainability Team)

重視綠色轉型與主動信息披露  ESG表現屢獲國際權威認可

復星國際一直堅定履行對可持續發展的長期承諾,在全球主流ESG評級中屢獲佳績。截至目前,復星國際MSCI ESG評級已升至最高級AAA;入選標普全球《可持續發展年鑑2026》,同時在《可持續發展年鑑(中國版)2026》中連續第三年名列最佳1%;復星國際恒生可持續發展評級從AA-越級提升至AA+,並連續第七年入選恒生可持續發展企業基準指數成份股,同時入選恒生ESG 50指數成份股;富時羅素FTSE ESG評分持續領先全球行業平均水平,並連續五年入選富時羅素社會責任指數(FTSE4Good Index Series)成份股。

近年來,復星國際持續深化ESG管理體系建設,將可持續發展理念深度融入戰略決策、日常運營與風險管理全流程,全面提升集團及成員企業在可持續發展議題上的管理能力與執行成效。與此同時,復星國際積極響應國家「雙碳」目標,持續推進碳中和、節能減排及氣候風險管理,並於2026年繼續以自願性質發佈第四份氣候信息披露報告,進一步提升氣候相關信息披露的系統性與透明度。

積極應對氣候變化  守護生物多樣性

集團同時積極推動成員企業開展氣候行動。集團在上海的主要辦公場所—上海地標性建築外灘金融中心(BFC)在規劃初期即引入並遵循被譽為綠色建築界的「奧斯卡」LEED 標準。2025 年,Club Med旗下97%符合條件的度假村通過審核並獲得全球可持續旅遊權威標準—Green Globe 認證;三亞亞特蘭蒂斯、太倉阿爾卑斯國際度假區及麗江地中海國際度假區獲 LEED 金級認證等,展現復星在綠色建築與可持續旅遊領域的持續努力與成果。

在授予復星國際「最佳披露與轉型獎」以表彰公司堅定推進低碳轉型的積極行動和高標準信息披露外,《財資》還同步頒發了「最佳環境責任獎」予復星國際,高度肯定公司在應對氣候變化與生物多樣性保護方面的深度投入,其中更特別嘉許了三亞亞特蘭蒂斯水族館「海龜之家」項目。

早在2018年,復星旗下三亞亞特蘭蒂斯水生野生動物救助站便已正式成立,多年來已累計救助野生海龜42隻。今年5月23日「世界海龜日」當天,三亞亞特蘭蒂斯水族館「海龜之家」正式揭牌啓用。輕傷海龜經治療康復後會被重新放歸大海,而無法重返野外的海龜則留此長期安居。「海龜之家」佔地388平方米,設有康養水池、科普館及模擬自然生態環境的繁殖沙灘,為救助海龜提供全方位的康復與棲息保障。

創新驅動  創造長遠社會價值

復星堅持創新驅動戰略,推動旗下業務不斷結出創新成果,以更好服務社會。在健康產業領域,復星圍繞未滿足的臨床需求,深度佈局腫瘤、免疫炎症、神經退行性疾病等核心治療領域,積極拓展慢病及罕見病等領域,打造具有長期競爭力的產品管線與綜合解決方案;同時持續夯實抗體、ADC、小分子、細胞治療等核心技術平台,並拓展核藥、小核酸等前沿技術。創新產品已在全球90多個國家和地區銷售,2026年上半年,7個創新藥品共20項適應症於境內外獲批上市,漢斯狀、HLX43等上市及在研創新藥實現多項「全球首個」突破。

世界公共衛生方面,截至2026年上半年,復星醫藥已累計向全球市場供應超過4.6億支注射用青蒿琥酯,累計救治了全球超9,200萬重症瘧疾患者。

深耕社會責任  科技賦能基層醫療

為更好地推動企業社會責任的履行和實施,復星基金會於2012年成立,在全球應急馳援、鄉村振興、健康、教育、文化藝術及青少年發展等領域不懈努力,創造社會價值。 本次《財資》在授予復星國際「最佳社會責任獎」時,特別嘉許了「鄉村醫生」的企業社會責任項目,並表揚其將「AI村醫助手」帶入基層,提升醫療服務覆蓋面與效率。

復星基金會「鄉村醫生」項目自2017年底啓動以來,已覆蓋全國16個省、市、自治區的78個縣,守護2.5萬名鄉村醫生,惠及300萬戶農村家庭。為推動人工智能賦能鄉村振興並加強基層醫療體系建設,復星基金會聯合阿里巴巴公益基金會推出「AI村醫助手」科技公益項目。該項目將多位權威醫學專家聯合編寫的《鄉村醫生診療口袋書》轉化為數字化數據庫,鄉村醫生通過手機或電腦界面即可隨時進行智能問答,高效輔助日常診療。

上行下效培養ESG文化,構建ESG長效管理體系

復星將可持續發展作為優先事項,建立了自上而下的ESG改進長效機制,不僅將ESG管理績效納入執行董事考核體系,更全面延伸覆蓋至集團CEO及各業務集團負責人。復星一直上行下效培養ESG企業文化,通過定期舉辦ESG全球網絡工作坊、ESG文化周及搭建「ESG學堂」數字平台,復星在成員企業間建立起開放透明的溝通渠道,持續分享最佳實踐並推動附屬公司ESG專項發展。同時,復星積極與利益相關方及評級機構等保持高效透明的溝通。此次榮獲《財資》「最佳可持續發展團隊獎」,足見市場對公司ESG管理及公司積極推動環境保護、社會責任、公司治理各項工作的認可。

面向未來,作為一家植根中國的全球化企業,復星將繼續秉承「助天下」的初心,繼續通過創新和負責任的全球運營,積極承擔更多社會責任,矢志創造更加負責任、包容和可持續的未來。

Information Provided by PR Newswire [Disclaimer]
09:26
Microsoft to Rely More on In-house AI Chips, Reduce Dependence on NVIDIA

Microsoft Corporation (MSFT.US) said it will step up the use of its in-house artificial intelligence chips after years of relying on graphics processors from NVIDIA Corporation (NVDA.US), aiming to strengthen its AI technology stack.

After unveiling its third-generation Maia AI accelerator on Monday (12th), Microsoft said it will mainly rely on its own chips to process AI inference requests in the future.
~

AASTOCKS Financial News
Website: www.aastocks.com

Information Provided by AAStocks Financial News [Disclaimer]
2026-10-12
20:35
XPENG Launches the G9L Next-Gen AI Flagship SUV in Europe, Debuts NGP and Expands Global Technology Collaboration at 2026 Paris Motor Show

- XPENG officially launches the G9L Next-Gen AI Flagship SUV for Europe, with French pricing starting from [€74,990].

- XPENG NGP powered by VLA 2.0 makes its first large-scale test-ride appearance in Europe. At the Paris Motor Show, NGP is also being showcased in the official Autonomous Lab, which is open to public experience, with XPENG being one of only two participating automakers, alongside Tesla.

- XPENG introduces its AI and vehicle engineering technology solutions overseas for the first time, opening new opportunities for technical collaboration with global automotive and tech partners.

PARIS, Oct. 12, 2026 /PRNewswire/ -- XPeng Inc. ("XPENG" or the "Company," NYSE: XPEV; HKEX: 9868), a leading global Physical AI company, today launched the G9L Next-Gen AI Flagship SUV for Europe at the 2026 Paris Motor Show, alongside the first global public test ride campaign of XPENG Next Generation Pilot (NGP) powered by VLA 2.0, as well as announcing new technology collaboration opportunities for global automotive partners.

Across its flagship XPENG Paris Night event and the Paris Motor Show, the company showcased three areas at the center of its next phase of global growth - bringing its latest-generation flagship G9L to European users, introducing NGP to European roads, and opening more of its AI and vehicle engineering capabilities to global automotive partners.

Together, these developments advance XPENG's "In Europe, For Europe, With Europe" approach, combining global technology with European R&D, local production and deeper collaboration with partners.

XPENG Paris Motor Show Press Kit:
https://drive.google.com/drive/folders/1I8SLTqDREdDCzeY5YUu8LjLe7jlPI6e2 

G9L: XPENG's Next-Gen AI Flagship SUV

Taking center stage in Paris, the G9L brings together intelligent driving, advanced safety, flagship comfort and long-distance capability. Designed around different lifestyles and journeys, from business and family travel to outdoor adventures, the G9L will be priced from [€74,990].

Built around the principle that safety is the ultimate premium, the G9L combines active prevention, passive protection and system redundancy, including nine airbags as standard, automatic emergency braking at speeds of up to 150 km/h and stability support following a tire blowout. It has undergone three years of testing across 26 countries and regions, covering more than 6.74 million kilometers.

Beyond safety, the G9L combines a sophisticated chassis with two seating layouts: 6‑seater and 7‑seater, plus luxury AI-Adaptive Front Seaters. EV variants offer up to 591 km of WLTP range, while its 800V architecture and 5C charging technology enable 10% to 80% charging in as little as 11.7 minutes. Following its successful production trial at Magna in Graz, the G9L is also set to become the fourth XPENG model manufactured in Europe.

XPENG NGP Comes to European Roads

XPENG also introduces XPENG NGP powered by VLA 2.0, supported proprietary Turing AI chips, 4D spatiotemporal understanding and strong generalization across different roads and unfamiliar scenarios. VLA 2.0 can retain up to 30 seconds of contextual information and predict how a scenario may unfold up to six seconds ahead, helping NGP understand, anticipate and respond to changing road conditions. The technology has been tested against complex European driving conditions.

In Paris, NGP is making its first large-scale test-ride appearance in Europe, demonstrating its capabilities across roundabouts, narrow streets, motorcycle traffic, pedestrian crossings and complex right-of-way situations. At the Paris Motor Show, NGP is also being showcased in the official Autonomous Lab, with XPENG one of only two participating automakers.

The test rides demonstrate NGP in European road scenarios including Paris roundabouts, narrow streets, motorcycle traffic, pedestrian crossings and complex right-of-way situations.

XPENG also aims to become the first certified automaker in the world to meet UNECE UN Regulation No. 171, Series 02, supporting the global expansion of its advanced driving software.

Bringing Physical AI to Life in Paris

The three announcements form part of XPENG's broader Physical AI vision on display at the Paris Motor Show, where the company has transformed its 1,008-square-meter stand in Hall 6, Stand A51 into a "Physical AI Museum," bringing together intelligent vehicles, humanoid robots, flying mobility and the underlying technologies that connect them.

The Press Day display brings together 11 vehicles, including the G9L, L03, P7+, G6, G9 and X9, alongside one Land Aircraft Carrier and two IRON humanoid robots. Dedicated technology areas showcase VLA 2.0 and the Turing AI Chip, as well as XPENG's latest developments in humanoid robots and flying mobility. IRON, XPENG's advanced general-purpose humanoid robot, is planned for global rollout in 2027.

In Europe, For Europe, With Europe

XPENG's Paris presence marks a further step in its "In Europe, For Europe, With Europe" approach. Globally, XPENG now operates across 82 countries and regions, supported by eight R&D centers, six manufacturing bases and 1,283 stores.

In Europe, XPENG combines an expanding product portfolio with deeper local R&D and production capabilities. Its European R&D center supports homologation, language interaction, chassis tuning, charging integration and intelligent-driving validation, while local production with Magna in Austria began in Q3 2025.

With the G9L joining its European portfolio and NGP powered by VLA 2.0 being validated against European driving scenarios, XPENG is bringing more of its global technology to Europe, developing it with European expertise and partners, and adapting it for European users.

ENDS

About XPENG

XPENG is a leading global Physical AI company, dedicated to bringing artificial intelligence into the physical world to reshape future mobility and smart living. Through in-house R&D, XPENG has developed a full-stack Physical AI architecture spanning Turing AI chips, world foundation models, and highly integrated software and hardware applications. This unified technology foundation powers an expansive product portfolio of smart EVs, robotaxis and humanoid robots, advancing the deployment of Physical AI at scale.

Headquartered in Guangzhou, China, XPENG is dual-primary listed on the New York Stock Exchange and the Hong Kong Stock Exchange. With global capabilities across R&D, manufacturing, sales and services, XPENG drives continuous technological innovation and fosters an open Physical AI ecosystem, making life smarter, safer and better for users worldwide.

For more information, please visit https://www.xpeng.com/

Information Provided by PR Newswire [Disclaimer]
17:33
FORTUNE Future 120: 11 CN Firms Selected; NVIDIA, OpenAI, Apple Make List

Fortune and Boston Consulting Group (BCG) recently released the 2026 Fortune Future 120, a ranking of the world's 120 companies with the greatest future growth potential. The list screened more than 3,500 companies globally based on three dimensions: growth ambition, talent density and growth culture.

US tech giants NVIDIA Corporation (NVDA.US) (ranked 16th), OpenAI (18th), Apple Inc. (AAPL.US) (55th), Tesla, Inc. (TSLA.US) (87th) and Meta Platforms, Inc. (META.US) (120th) were all included on the list.

A total of 11 Chinese companies were selected, with UBTECH ROBOTICS (09880.HK) ranking first among Chinese enterprises. In addition, Moore Threads (23rd), Advanced Fiber Resources (32nd), Biren Technology (46th), Changchuan Technology (60th), SENSETIME (73rd), HORIZONROBOT (85th), XPENG (100th), ByteDance (104th), iFlytek (116th) and Cambricon (117th) also made the list.
~

AASTOCKS Financial News
Website: www.aastocks.com

Information Provided by AAStocks Financial News [Disclaimer]
16:26
UK Govt Plans to Mandate Frontier AI Companies to Submit Safety Reports and Monitoring

The UK government is formulating plans to mandate frontier AI companies to submit safety reports and monitoring data, while preparing to require companies to impose stricter controls on autonomous models, Financial Times, citing sources, reported.

UK AI minister Kanishka Narayan is reportedly expected to deliver a speech on Monday (12th), stating that companies developing increasingly powerful and autonomous AI models must take more measures to address risks and establish safety safeguards. He will emphasize that the government is prepared to strengthen regulation of AI development through legislation.
~

AASTOCKS Financial News
Website: www.aastocks.com

Information Provided by AAStocks Financial News [Disclaimer]
09:02
NVIDIA Reportedly In Talks for Further Investment in or Acquisition of Reflection AI

NVIDIA Corporation (NVDA.US) is in talks to increase its investment in open-source startup Reflection AI or acquire the company, although negotiations remain at an early stage, Financial Times, citing sources, reported.

The transaction could take multiple forms, including NVIDIA hiring Reflection AI employees and obtaining technology licenses instead of conducting a full acquisition, in order to avoid potentially lengthy regulatory reviews.

The two companies are reportedly likely to reach an agreement in the coming weeks. NVIDIA is already a major financial backer and strategic investor in Reflection AI, having invested USD800 million in the company.
~

AASTOCKS Financial News
Website: www.aastocks.com

Information Provided by AAStocks Financial News [Disclaimer]